News

Regeneron (REGN) Scores FDA Approval, JP Morgan Reaffirms $800 Price Target
On the other side, on July 7, JP Morgan analyst Chris Schott reiterated a Buy rating on Regeneron, while maintaining his $800 ...
Bank of America Securities Reiterated a Sell rating on Regeneron Pharmaceuticals (REGN), Lowered the PT
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is one of the Best Extremely Profitable Stocks to Buy Right Now . On July 22, ...
Barchart on MSN8h
Regeneron Pharmaceuticals Earnings Preview: What to Expect
Tarrytown, New York-based Regeneron Pharmaceuticals, Inc. (REGN) discovers, invents, develops, manufactures, and ...
Gilead Sciences (GILD) Receives a Buy from J.P. Morgan
Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.